
ã20220706å·ã10 幎éã®ãããŒå°å·ã®å»¶é·ã 7 æ 4 æ¥ã«æéåãã13 ã·ã£ã㊠ããªã¿ãªãŒãº ãªãŒã« ãŽãŒã³! ååãããæ°ãããŠã€ã«ã¹ãã¯ãªããã³ãã«ã¹çãã«ã³ãžãã¢ãŠããã¬ã€ã¯è»¢çšããã©ã³ãšã®å¥çŽæºäºã æ®ãã®æãè ã«ã¯åéãæ®ã£ãŠããŸãã
ãžã£ã¹ãã»ãšã³ãã¯ãŒã»ããŒã®èšäºãã
10 幎éã®ãããŒå°å·ã®å»¶é·ã 7 æ 4 æ¥ã«æéåãã13 ã·ã£ã㊠ããªã¿ãªãŒãº ãªãŒã« ãŽãŒã³! ååãããæ°ãããŠã€ã«ã¹ãã¯ãªããã³ãã«ã¹çãã«ã³ãžãã¢ãŠããã¬ã€ã¯è»¢çšããã©ã³ãšã®å¥çŽæºäºã æ®ãã®æãè ã«ã¯åéãæ®ã£ãŠããŸãã
/ã¢ã«ãã¡ QMS ,ã¢ãŒãââãã¹ã, ARCHONS ,ã«ã³ãžã,ã±ã ãã¬ã€ã«,äžåœã®é·è,ã¯ãªã¹ãã¹ ã¹ãã€ã·ã¹ã®ååš, 9 ã®è©è°äŒ,ã«ã€ã³ã®çµç€Ÿ: ãœãã¢ã³ã®æªéã®ç³»å, é»ã倪éœ, COVID/çç©å µåš/ãã©ã³ãããã¯,ã¯ãªããã³ãã«ã¹ç, DARPA ,芪æãªã人é¡,ããã«ãã»ãã©ã³ã,ãã©ã³åå®,ãã©ã³/ã¢ã«ãã¡ã»ãã©ã³ãã¹,ãã©ãŽã³ãã¡ããªãŒ,ãšã·ã¥ãã³,æœè¡,宿œããŒã ããã§ã ããã¯ãããžãŒããžã§ãŒãžã¢ ã¬ã€ã ã¹ããŒã³ãºãGLUE ãã¬ãŒã ã¯ãŒã¯ãã€ãšãºã¹äŒããã¢ã³ ãªãµãã³ããã ã€ã³ãã«ããã³ããªãŒ ãŽãŒã²ã³ | å°äžåžä»€éš - ã¬ãŒãã£ã¢ã³ - å°ç倧䜿 - GIA ã®ç®¡å¶å® - ã¢ã«ãã¡ã·ã¹ãã ã®ç®¡å¶å®ããªãµã»ã¬ã㌠| Energetic SynthesisãLucifer Quantum Super ComputerãMardukãMilabãMilitariesãProject WalwriterãPrometheusãPROMISãRNA/GNAãShadow Agencies/OperativesãShadow Militaries/Operatives , The Enforcer , The Others/36 Races/Earth Council , Uluru , Universal Council / By jemgroup
ãã® ç¶æ³ã¬ããŒã:ãã ãŽãŒã²ã³ ã«ãã é瀺ã¯ã 2022 幎 7 æ 6 æ¥ã« UNN ã®å å ¥è ãå©çšã§ãããŠãã€ããã ãã¥ãŒã¹ ãããã¯ãŒã¯ã§ é ä¿¡ãããŸããã
ãã®ã¢ããããŒãã«å«ãŸããã®ã¯ãçŽå¹£ãå°å·ããããã® 10 幎éã®å»¶é·ã®èµ·æºããã©ã³ãäžçäžã§åæ»ç¶æ ããæãåºãããšãå«ã 13 ã®ã·ã£ã㊠ããªã¿ãªãŒãçµããããããã€ãã®äœæŠãè§£ãæŸãããããå€ãã®ãŠã€ã«ã¹ã転çšãããããšããã¢ã³ ãªãµãã³æ¿æ²»ãã£ã¯ãµãŒãšãã©ã³ãããŒã ãšã®å 茪ããã


10 幎éã®çŽå¹£å°å·å»¶é·ã®èµ·æº
ãã ã«ããã°ã2012幎äžã«ã圌女ããã«ãã¥ã¯ã®å°äœãåŒãç¶ãã§ããããšããã£ãŒãã¹ããŒãã®äººã ãšãªãŒããŒã«çºè¡šãããŸãããå ·äœçã«ã©ã®ã¬ãã«ãã¯ããããŸããã圌女ã¯ãããã®è©³çްãæããŠãããŸããã§ãããããããã®åŸã圌女ã¯äœé±éããããŠãã«ãã¥ã¯ãšäŒè©±ãããã«ãã¥ã¯ã¯åœŒå¥³ã圌ã®ç®¡è²¡äººã§ããã圌ã®ããã«åããŠããããšãçŽåŸãããããšããŸããã 圌女ã¯ã圌ãèªåã®äžåžã ãšæã£ãã®ã¯ééãã ã£ããšèªãããããã¯ããã«ãã¥ã¯ããã®ãããªæçŽãæžãããšã«ãã£ãŠåœŒå¥³ã«æç€ºãäžãããšãã圌女èªèº«ã®èªãã«ãã£ãŠãå¥ã®ããªã倧ããªééãã«ã€ãªãããŸãããã¹ã¯ãªãŒã³ã·ã§ããã«æéãå«ããã®ã§ãèªåã§è¡ãããå Žåã¯ããããªã®ã©ãã«è¡šç€ºãããŠãããã確èªã§ããŸããæçŽã«ã¯æ°ããŒãžãããŸãã

æçŽã¯åºæ¬çã«ãè«æ±æžã¯ç±³åœã ãã§ãªãããµãŠãžã¢ã©ãã¢ããã·ã¢ãããã€ãã®æ©é¢ãMI5ãããã³ MI6 ã®ãã¹ãŠã®éšéã«æéãããããšãæŠèª¬ããŠããŸãã圌(ãã«ãã¥ã¯)㯠2012 幎 5 æã«åœŒå¥³(ãã )ã«æçŽãéãã7 æ 4 æ¥ãŸã§ã«å®æãããªããã°ãªããªããšäŒããŸããã圌ã¯åœŒå¥³ã«äœããã¹ããæç€ºãåºããã圌女ã¯ããã®æçŽã«èšèŒãããŠãããã¹ãŠã®éšéã«é(ãããGOLD)ãå²ãåœãŠãããšã«ãªã£ãŠããŸããããã ã«ã¯ç¥ãããŠããªããã圌女ã¯ãããããã圌女ã¯ãã®æãèªåã®ä»äºãããŠããã ãã ãšæã£ãŠããŸãããæ®å¿µãªããšã«ãããã¯éåžžã«å€é¡ã®éãšæ°å ãã«ã®æ¿åºéšéãžã®å²ãåœãŠã«ã€ãªãããããããåœæã¯é£éŠæºåå¶åºŠãéããŠãã£ã«ã¿ãªã³ã°ãããŠããŸããããããªã§ã¯ãçŽ 48 æã®çŽå¹£ã衚瀺ãããŸããããããã¯ãã¹ãŠã»ãšãã©åãããã«èŠããŸããããã®ãã¡ã® 1 ã€ã®äŸã次ã«ç€ºããŸãã

https://unitednetwork.nunchee.tv/content/detail/62c630cb68dd76001a098b62/06-07-2022-United-Network-Global-News-Desk
åœéçºæ¿æåœ¢è£é¢ ã·ãªã¢ã«ãã³ããŒïŒMG10022 é¡é¢ïŒ1å
USãã« ãªãŒãµãªã³ã°ãã£ãŒ/ã·ã°ãããªãŒ FMCA/EMM/FEM 7778887778889999 TRUSTã®åèšè
ã§ããKimberly A. Goguen. ãã£ã¬ã¯ã¿ãŒå
Œ ã¡ããã°ã©ã³ãããŒã«ãã£ã³ã°ã¹ã®ã°ããŒãã«ãã³ãã³ã°æ
åœãã€ã¹ãã¬ãžãã³ããã圌ã®å
šæš©ã§è¡åããŠããŸãã
ä¿¡èšæç€ºæž æ¯ææé 2012幎6æ15æ¥ 2012 幎 7 æ 2 æ¥ æ¥ä» åé ãã察䟡ãšããŠãããã«è²æž¡ã»ç§»è»¢ããïŒ ãã¹ã¿ãŒã¢ã«ãŠã³ãïŒ10-543-2101 01-5432101CASHLSM-101012345 0110123450CASHLSM-10-054321-01 01-0545321CASHLSM-1012345450 43:25 1:53:08 10-1106616160CASHLSM-0106166011 10-76543211CASHLSM0111234567 10-061610CASHLSM01015160 10-102101CASHLSM01-101201
å£åº§çªå·/æå±æ©é¢/äœæ ç±³åœèŸ²åç-宿œ/éçšã®ããéå¶äºç® æ²ç« ã®äžã« æé«éžæäºº ucc filing and confirmed ã«åºã¥ããŠæåºãããæ¬æžã®æ
ä¿ã
æ¬æžã®å®¿æ³ãšåœç€Ÿã®å£åº§ãžã®è²æž¡ã«ãã ã¡ããã®è³ç£ããã¡ããã®è³ç£ãž é(ãããGOLD)æºåãå²ãåœãŠã å¶åŸ¡èšåã³ãŒã DT271840 å¶åŸ¡æœèšã³ãŒãã§ãïŒ 4800982-8278 1.m.s. 378009827 2. D.S. 48609874 3. C.N. 46898271 4. R.S. 27860982 P ã³ãŒã 54430089711ãæææš©äž»åŒµ NHT 654008979911/NBG 76500008ã ä¿éºïŒ6453008979930-MNT-561610ããŽãŒã«ãã³ãŒãïŒ 4318867577110-HT-675775 CFT ã¹ããŒãã¡ã³ãããã°ã©ã FMCA CFT Documents/NH/541007868833CFD, GFT 5410078688844ã
ãã©ã¹ãã»ãªããªã²ãŒã·ã§ã³ äžççµæžã®å埩 ã³ãŒã/A 7778887778889999 åç
§ïŒ ã°ã¬ã€ã¹ã¯ãªãŒã³ UN04050 ããŒã ã©ã³ã 4051100-92 (118-65)
ããã¯ããªãã®æŽæ¿¯ç©ãªã¹ãã§ããã圌女ã¯ãªã¹ãå šäœã調ã¹ãŠãããããã¹ãŠãå²ãåœãŠãŸãããããã«ãããåéšéã«å²ãåœãŠãããäžå®éã®é(ãããGOLD)ãšãããã€ãã®çŸéå£åº§ïŒãã¯ãååšããªãïŒããã®å²ãåœãŠãäžããããŸãããããããå®éã«èš±å¯ãäžããã®ã¯ãã ã§ããã圌ãã¯ãã®è³éã®ã»ãšãã©ã 5ã6 幎åã«äœ¿ãæããããã以æ¥ãæ°ããå²ãåœãŠãæ¢ãç¶ããŠããŸãã
äžåœã®é·è/ãã©ãŽã³ãã¡ããªãŒã¯ã圌ãããœãŒã¹ã§ãããšäž»åŒµããŠåãã€ãã
é£ç©é£éã®äžæµã«ãã人ã
ã¯ãäžåœã®é·èããã©ãŽã³ãã¡ããªãŒããããã®ãéã¯éšå£«å£ããæ¥ããã®ã ãšèšãããããæ±ºããŠããããªãã£ããåã¯ãé»ã倪éœã®éšå£«å£å
šäœã§æ°žç¶åãããŸããããã ã¯ãŸããRV ããã®æ¯æããæåŸ
ããŠãããã¹ãŠã®äººã¯ããªããã®æã« RV ãèµ·ãããªãã£ãã®ãçåã«æãã¹ãã ãšä»ãå ããŸããã圌ãã¯10幎éãå²ãåœãŠããããã¹ãŠã®éãæã£ãŠããŸãããã§ã¯ããªã圌ãã¯æ¯æããããªãã£ãã®ã§ããããïŒ
ãµããããããããæåãããããªã€ãããããªãã£ãããïŒç§ã¯ã¡ããã©æšæž¬ããŠããŸãããããŒå°å·ã®å»¶é·ã¯ 2022 幎 7 æ 4 æ¥ã«çµäºããŸãã
è¯ããã¥ãŒã¹ã¯ã10 幎éã®å»¶é·ã 2022 幎 7 æ 4 æ¥ã«æ£åŒã«çµäºããããšã§ããäžèšã§åœŒå¥³ã¯ãå»¶é·ãã©ãããå§ãŸã£ããã説æããŸããã圌女ã¯ãé廿°å¹Žéã7 æ 4 æ¥ã«åœŒãå šå¡ãæ°ããè³éã®å²ãåœãŠãæåŸ ããŠãããšèšããŸãããããã¯ãã©ã³ãæ¿æš©ã®éã«èµ·ãããçŸåšã¯ãã€ãã³æ¿æš©ã®éã«èµ·ãããŸããããäœãæ¥ãŠããŸããããªãïŒãã ã¯æåŸã«ãããè¡ã£ã人ç©ã§ãããçã£ãäžåœäººãããã³ãã³ãäžæ±ããŸãã¯æ°éã®è»éãªã©ã®å¯Ÿå¿è ã§ã¯ãããŸãããããã¯ããã«ãã¥ã¯ãã圌女ã«äžããããåœä»€ããçŽæ¥æ¥ãŠãåœŒã¯æ»ãã§ããŸãã
13 圱ã®è»é | ãŒããªã¡ã€ã³ïŒ
ãã ã¯ãæ°æ¥åã®æç¹ã§ã圌女ã®é瀺ã¬ããŒãã®ããŒã 2 ã§èª¬æãã 13 ã®åœ±ã®è»éãæ®ã£ãŠããªããšèšããŸããã6 æ29æ¥ãŸã§ã«ã圱ã®è»é㯠11 ãŸã§æžå°ããŸããã圌女ã¯ãæéåãã«ã€ãªãã£ãããã€ãã®æäœã匷調ããŸããããã®æçš¿ã«ã€ããŠã¯ãã·ã£ã㊠ããªã¿ãªãŒã® 13 ã®ã°ã«ãŒã |ãåç §ããŠãã ãããè«å ±æ©é¢ã¯ã©ã®ããã«æ§æãããã | 41 人㮠Coven ã¡ã³ããŒããŸã èŠæŠã匷ããããŠããŸããããŒã2
å°äžåžä»€å®ãã ããã¯ã€ãããŠã¹ã§äœæŠãå®è¡
ãã ã¯ã誰ããã¯ã€ãããŠã¹ãå®éã«éå¶ããŠããã®ããçºèŠããã圌ãã¯ãã¯ã€ãããŠã¹ã®å°äžã«ããæ©èœå£ã«ããŸãããããã«ã¯äœæŠãå®è¡ããå¿ èŠããããä»å圌女ã¯å€äº€ã©ã€ã³ã§ã·ãŒã¯ã¬ãããµãŒãã¹ã«é»è©±ããŠã圌ãã«åå ãããããšã«ããŸããã
圌女ã¯ã人éã§ããæ¿æ²»ã®å°éå®¶ã§ãããã©ã³ïŒã€ã¥ããããããªãïŒã®è»äººïŒãããŠããã ã圌女ã®é瀺ã¬ããŒãã®ããŒã3ã§ç§ãã¡ã«æŽæ°ããåœ±ã®æ©é¢ã«è©²åœããïŒããã³ã«ãŒã«ããŸããããäžäººã§ã¯ãªãã£ããšèšããŸããã 圌ãã«ã¯äŒç€ŸããããŸãããå®éã圌ãã¯åæ»ããè§£æŸãããã°ããã®æ°äººã®ãã©ã³ãšäžç·ã«ããŸãããæ³åããŠã¿ãïŒãã®æçš¿ã«ã€ããŠã¯ãThe 5 Shadow Agency |ãåç §ããŠãã ããããã ã®ãã©ã³ãšã® 30,000 幎æŠäº | ãã ã®ã¯ããŒã³ã®éå»ãšçŸåš | ããŒã 3 |
ãã©ã³ã¯ãã¯ã€ãããŠã¹ã®äžã«ããã ãã§ãªãããã®ç¹å®ã®æ¥ãè³ãæã®ããŸããŸãªæœèšã«åºãŠããŸãããããã§åœŒå¥³ã¯ã·ãŒã¯ã¬ãã ãµãŒãã¹ã«é£çµ¡ããŠããã³ã«ãŒã§å®éã«äœãèµ·ãã£ãŠããã®ããèŠããŠãããããšã«ããŸããã圌女ã¯åœŒãã«éšããåŒãèµ·ããã ãããšèšããŸãããã圌女ãšåœŒå¥³ã®ããŒã ã¯ãããã®äººã ãæé€ããã·ãŒã¯ã¬ãããµãŒãã¹ã¯ãããã®æ»äœãæé€ããªããã°ãªããŸããã§ããã圌女ãèšã£ãããã«ããããã³ã°ããããæ¬ç©ã§ã¯ãªãã£ããšèšãããšãã§ããã®ã§ãé²ç¯ã«ã¡ã©ã§èŠãã®ã¯1ã€ã®ããšã§ããå°äžå®€ã«è¡ã£ãŠå€§è殺ãèªåã§åãé€ããªããã°ãªããªãå Žåãããã¯å¥ã®ããšã§ãããã ã¯ãéåžžã¯èª°ã«ãé»è©±ããããªãã ãããšèšããŸããããä»åã¯åœŒãã«äœæŠã®æ§åãèŠããããšã«ããŸããã
ãã³ã¿ãŽã³ãš GCHQ ã§åæã«éçšãå®è¡
åæã«ããã¯ã€ãããŠã¹ã§èµ·ãã£ãŠããããšã¯ããã³ã¿ãŽã³ãš GCHQ ã§ãèµ·ãã£ãŠããŸããããã ã¯åãæäœãå®è¡ããŸããã圌女ã¯åœé²ç·çã®åžä»€éšã«é£çµ¡ãã圌ãã®è¶³å ã§äœãèµ·ãã£ãŠããããäŒããã«ã¡ã©ãè£ çããããã«äŒããŸããã圌ãã¯ã人éãšäººé以å€ãçžäºäœçšãããã¹ãŠã®ã³ã³ãã¥ãŒã¿ãŒã·ã¹ãã ãééããè¡ãã¹ãã§ã¯ãªãããããã¹ãŠã®ããšãè¡ã£ãŠããã®ãèŠãŸããã
ãããã£ãŠããã¯ã€ãããŠã¹ãå®éã«éå¶ããŠããã®ã¯ãã©ã³ãã§ã¯ãªããç§ãã¡å šå¡ãæãããšããŠããã®ã¯ç¹å¥åçã®ãã¯ã€ãããã¿ãŒã§ã¯ãªãããã©ã³ãšäººéã®éãŸãã§ããããã³ã¿ãŽã³ã§ãåãããã¹ãŠæã¡åºãããŸããã圌女ã¯ãé»åæ©åšãééããç°åšæ³¢å µåšã䜿çšããŸããã圌ãã¯ãŸããããã«ãã£ãã·ã¹ãã ãåãåºããŸããããŸã å¿ èŠãªãã®ãããå Žåã¯ãææãæ¥ãã亀æããŸããšåœŒå¥³ã¯èšããŸãããä»ã®ãšããã圌ãã¯é ã®äžã§èª°ãæ£ãããªãããç¹å®ããããšã«éäžããå®¶ã®æé€ãéå§ããå¿ èŠããããŸãã
é¢äžãã 2 ã€ã®åœ±ã®è»éã®æ®ãã¯ããã·ã¢ã§çºèŠãããŸããã圌ãã¯ã¢ã¹ã¯ã¯ã®å°äžãã³ãã«ãèµ°ã£ãŠããã圌女ã¯ãŸãã圌ããåãæ¥ã«äžåœã§118ãèŠã€ãããšèšããŸããã圌ãã¯äžåœã®ãã£ãŒã ã¹ããŒãã®å°äžçµç¹ãšååããŠãèªåãã¡ããè³¢ããšæãããå¥ã®çš®æããæç€ºãåããªãããããŸããŸãªå Žæã§æŽ»åããŠããŸãããã€ã³ã¿ãŒããŒã«ã®å»ºç©ã®äžã«ã¯ããã©ã³ã¹ã®ãã©ã³ã補é ãŸãã¯ã¯ããŒã³åããæœèšããããŸããããããã®äœæŠã«ããã13 ã®ç§å¯è»ã®ãã¡ 2 ã€ãåŠçãããŸããã
ãã¡ãªã¿ã«ãLisa Reneeã«ãããšãã¹ãã€ã·ã¹ã«ãè¯ã人ãããŸããã¯ãªã¹ãã¹ã»ã¹ãã€ã·ã¹ã»ããŒã€ã³ã°ã«é¢ãã圌女ã®ã¢ã»ã³ã·ã§ã³çšèªéã®ãšã³ããªã¯ãç§ã®æèŠã§ã¯éåžžã«ã¯ãŒã«ã§ãããããã¯ãªãã¯ãããšãã®ãšã³ããªã«ãžã£ã³ãããŸããã
ããŒã³ãè»
ãããžã§ã¯ãã»ãŠã©ã«ã©ã€ã¿ãŒ
ç±³åœã«ã¯ 2 ã€ã®å€§ããªæœèšããããŸããã1 ã€ã¯ã¢ãªãŸãå·ããã¹æ¹ã®äžããã 1 ã€ã¯ã³ãã©ãå·ããã·ã ããŠã³ãã³ã«ãããŸãããããã®æœèšã¯ãKim ãéå»ã®æŽæ°ã§äœåºŠã話ãã Project Walwriter(ãããžã§ã¯ãã»ãŠã©ã«ã©ã€ã¿ãŒ) ã«äœ¿çšãããŠããŸããããšã»ãªã¢ã«ãªãã©ãµã€ãã䜿ã£ãŠã¢ã«ãã¡ã·ã¹ãã ãžã®ã¢ã¯ã»ã¹ã詊ã¿ãŠããŸããã
圌ãã¯ãŸããProject Walwriter(ãããžã§ã¯ãã»ãŠã©ã«ã©ã€ã¿ãŒ) ã䜿çšããŠæãè»éããå€ããå³åº§ã«æŽªæ°ŽãåŒãèµ·ããããšãæå³ããŠããŸããããã¡ãããç®æšã¯ç§ãã¡å šå¡ãæ»ã¬ããšã§ããã¡ãªã¿ã«ãããããã ãšåœŒå¥³ã®ããŒã ããŸã æãåé€ããŠããªãçç±ã§ãã
å°çã«ã¯ããããžã§ã¯ã ãŠã©ã«ã©ã€ã¿ãŒã®äžéšã§ããã£ãããããšãã§ã ãããã¯ãå¢å¹ ããèœåãšããç¹å®ã®æ§è³ªããããŸãã圌女ã¯ãããããã®å·šå€§ãªçŸ€ãã®ããã«èŠãããã®ãçºèŠãããšèšããŸãããããã以å€ã¯ãã¹ãŠ AI (ãšãŒã¢ã€)ã§ããããããšãã§ã ãããã¯ã§ã§ããŠããŸãããããã¯èã®å·£ã®ããã«æ¯ãèã£ãŠããŸãããããã¯ãã±ã ãã¬ã€ã«ã«ãã£ãŠããŸãã¯ã©ã®ããã«ããããšããŠãããšããŠãã人éã®äœã«äŸµå ¥ããããã«åœŒããæžåœã«åãçµãã§ããããšã§ãã圌ããæåããã°ãããã 13 ã®è»éããã¹ãŠã®äººéã蟲æ¥ãå°çãæ¯é ã§ããããã«ãªãã§ãããã
ã€ã®ãªã¹æµ·è»ãããŒã¿ã« ã·ãŒã«ãä¹±ã
åãæ¥ã«ãã€ã®ãªã¹æµ·è»ã¯ããŒã«ã䜿ã£ãŠããŒã¿ã« ã·ãŒã«ãããã£ãŠããŸããããã ã¯ãæ°å¹Žåããã©ã³ããšãµãŠãžã¢ã©ãã¢ã®çåãã圌ãã倧ããããšããããã®ããŒã«ã®ããšãæã£ãŠãããšèšããŸããã圌ãã¯ãããè¹ã«ä¹ããŠå極ã«åãããè² ã®åšæ³¢æ°ãšéã®ãšãã»ã³ã¹ã䜿ã£ãŠãã©ã³ã¹ã厩ãããšããŠããŸãããTeRAD Terra Hertz ãã©ã¡ãŒã¿ãšåŒã°ãããã® (ã¹ãã«ã¯äžæ)ãè¹ã¯ç£æ¥µãã²ã£ããè¿ãããã«ç¹å®ã®å°åã«è¡ããŸãããããã¯ãç§ãã¡äººéå šå¡ã«æ¬åœã«åä»ãªãšãã«ã®ãŒãéã£ãŠããŸããã
幞ããªããšã«ãããã«ããšã³ãã©ãŒãµãŒãçŸããç¶æ³ãå®å šã«åŠçããŠããã€ã¹ãè§£äœããŸãããçŸåšãè±åœã¯äœäººãã®äººå¡ãä¹ãã1é»ã®è¹ã倱ã£ãŠããŸãã

ãªã€ãã§åéæ¿æŽŸã»ã³ã¿ãŒã®éæåŒã«èšãã¡ã©ãã¢ã»ãã©ã³ããšãã©ã³ã倧統é ã
å·Šããããšãžããã®ã¢ããã«ã»ãã¡ã¿ãã»ãšã«ã»ã·ã·å€§çµ±é ããµãŠãžã¢ã©ãã¢ã®ãµã«ãã³åœçã
ãµãŠãžã¢ã©ã㢠ãµãŠãžã¢ã©ãã¢ã»ãã¬ã¹ã»ãšãŒãžã§ã³ã·ãŒ
Sedlec-PrÄiceã® MILAB ã§ãšã€ãªã¢ã³ã®å¯çè«ã䜿çš
圌女ãèãã6æ29æ¥ãšåãæ¥ãå¥ã®MILABããã§ã³ã¹ãããã¢ã®Sedlec-PrÄiceãšããçºã§çºèŠãããŸããããã®åœã«ã¯ããã ããããŸã§ã«èŠãäžã§æãæã人äœå®éšå Žã® 1 ã€ããããŸãã圌女ã¯ãããæ¬åœã«åä»ãªæé»ãšãã«ã®ãŒã«èŠãããŠãããšèª¬æããŸãããMILAB ã®ããè¿ãã®çºã«ã¯ããããããã®æœèšããæ¥ããšæããã 40,000 人ã®äººéã®éªžéªšã§é£ŸãããæäŒããããŸãã圌ãã¯ãããŸããŸå¥ã®çš®ããå ¥æããããã€ãã®å€æ¥å¯çè«ã䜿çšããŠããŸããã幞ããªããšã«ããã ãå®éã«ã¯ã§ããªããšèšã£ãã®ã§ããšã³ãã©ãŒãµãŒã¯ãã®ã©ãã®äžè©±ãããŸããã圌女ãç 究宀ã«è¿ã¥ãã»ã©ãåœŒå¥³ã¯æ°åãæªããªããé ãå転ããã ãããšæã£ãã
ãã§ã³ã¹ãããã¢ã芳å ããŠããããããã«ç«ã¡å¯ããšã¯æããŸããããã®æäŒã«ã¯ç¢ºãã«äžæ°å³ãªãã®ãå«ãŸããŠããŸãã

4äžäœã®äººéªšã§é£Ÿããããã»ãã¬ãã¯ã®äžæ°å³ãªéªšæäŒ 2016幎07æ21æ¥ ããŒã«ã»ãããªãã¯
ã»ãã¬ãçŽéªšå ã¯ãã¯ãããŒåžéå€ã®ã»ãã¬ãã«ããå¢å°æäŒããªãŒã«ã»ã»ã€ã³ããã®äžã«ããããŒãã»ã«ããªãã¯ã®å°ããªç€Œæå ã§ããããã§ã³å ±ååœã®ãã©ã
ãã®çŽéªšå ã«ã¯ã4äžäººãã7äžäººã®éªžéªšãçŽããããŠãããšæšå®ãããŠããŸãã瀌æå ã®è£ 食ã調床åãšããŠãèžè¡çã«é 眮ããããã®ã§ãã
çŽéªšå ã¯ããã§ã³å ±ååœã®èгå åæã®ã²ãšã€ã§ã幎é20äžäººä»¥äžã蚪ããŠããŸãã

æ±äº¬ã® Cerebras Company ã¯ããããã¯ãããžãŒãšãã§ã ããã¯ãããžãŒã«éä¿¡æ©ã䜿çšããŠããŸã
æ°æ¥åã«å€§éªã®æœèšãè§£äœãããåŸã圌ãã¯æ±äº¬ã®Cerebras Companyã«ç§»ããããã§ç¹å®ã®éä¿¡æ©ã䜿çšããŠããããšãã§ã ãããã¯ã䜿çšããŠäººé¡ããã¹ãŠæ®ºãç¶ããããšãèšç»ããŸãããããã¯åœŒãã«ãšã£ãŠããŸããããŸããã§ããããããŠç§ãã¡å šå¡ããŸã³ãã§ã¯ãããŸãããç§ã¯ãŸã 森ã®éŠã§ããªãã®æ°ã«ééããŸãããèšã£ãŠãã ãïŒãšã«ããã圌女㯠2022 幎 6 æ 3 æ¥ã® Intel ã¢ããããŒãã§èšåãããã°ã«ãŒãã«ã€ããŠèšåããŠãããšæããŸããç§ã®å¯Ÿå¿ããæçš¿ã¯ãFemtotechnology, Not Graphene is the Replicating Tech in Vaccines/COVID Tests/Masks ã§ããäžåœã¯ãã©ãããããŒã¯ã§ãããã¢ãŒäžã®ããªãŒå°è» | ããè§£äœãããã·ã¹ãã | ãŠã©ãŒãã³ã°ã»ãããã®ãã¬ã人圢 | ããŒã2

è³æ¢ 補å ç£æ¥ ãªãœãŒã¹ éçºè äŒç€Ÿæ å ±-å ¥äŒ-ãã¢-Yin Q
æéã®Al.䜿ããããã çŸå Žã§å®èšŒæžã¿ã
ç§ãã¡ã¯ãæ¥çæå€§ã®ããã»ããµãŒãããŒã¹ã«ãæéã®Alã¢ã¯ã»ã©ã¬ãŒã¿ãŒãæ§ç¯ãã䜿ããããã远æ±ããŸãããCerebrasã¯ãè¶ é«éãã¬ãŒãã³ã°ãè¶ äœã¬ã€ãã³ã·æšè«ãèšé²çãªã¿ã€ã ãã¥ãœãªã¥ãŒã·ã§ã³ã«ãããæãéå¿çãªAlã®ç®æšãéæããããšãã§ããŸãã ã©ã®ããã«éå¿çãªã®ãïŒ200åãã®ãã©ã¡ãŒã¿ãæã€èšèªã¢ãã«ãã1å°ã®CS-2ã·ã¹ãã ã§ç¶ç¶çã«åŠç¿ãããããšã¯ãä»ã®ã©ã®ããã€ã¹ã§ãäžå¯èœãªããšã§ãããç§ãã¡ã¯ãããå¯èœã«ããã ãã§ãªããç°¡åã«å®çŸããŸãã 奜å¥å¿ãåºæ¿ããã³ã¹ããåæžããããšãã§ããŸãã
äž»èŠãªã¹ãŒããŒã³ã³ãã¥ãŒã¿ãµã€ã ã»ã¬ãã©ã»ãã©ãŒã»ã¢ã«ãéžã¶
ã¢ã¯ã»ã©ã¬ãŒã·ã§ã³ 詳ããã¯ãã¡ãâïŒè±èª
"å€§èŠæš¡ãªèšèªã¢ãã«ãã³ã¹ãå¹çãããç°¡åã«å€§è¡ã«æäŸããã»ã¬ãã©ã®èœåã¯ãã¢ã«ã«ãšããµã€ãã£ã³ã°ãªæ°æä»£ãåãéããã®ã§ãã äœåäžããããããªãçµç¹ã«ãã¡ãžã£ãŒãªãŒã°NLPãžã®ç°¡åã§å®äŸ¡ãªãªã³ã©ã³ããæäŸãããã®ã§ãã"
ã¡ããŠã¹ããªã¿ãªãŒ
ãã ãšããŒã ã¯ãè³å ã®äººéã®ç°çœè³ªãæäœããŠãåšæ³¢æ°ã浞éãããããããããšããŠãããšãã«ããã¥ãŒã¡ãã·ã³å·ã®ã£ãããã«ããæœèšãèŠã€ããŸãããç°çœè³ªã¯ç¬è«é¡è³ãšåŒã°ãããã®ã§ããã人éã«ãšã£ãŠèªç¶ãªãã®ã§ã¯ãããŸããã§ãããããã¯åœŒãã«ç§ãã¡ã®å€§è³ãžã®ã¢ã¯ã»ã¹ãã€ã³ããæäŸããã®ã§ãç§ãã¡ã¯ç¥ãšã®ã€ãªãããå°ãªããªããŸããã
ãã®æœèšå šäœãšããã«ãããã¹ãŠã®äººãé£ãåºãããŸãããã«ã¹ã±ãŒãã§å¥ã®æœèšãçºèŠïŒïŒã€ã¥ããããããŸããïŒãããã¯éèã·ã¹ãã ã«èªåèªèº«ãæ¿å ¥ããããšããŠããŸããããã®æœèšããªããªããŸããã
ããªããã£ããªã¿ãªãŒ
黿°éä¿¡äŒç€Ÿã®äž»èŠãªãµãŒããŒã®åé¡ãåœŒå¥³ã®æ³šæãåŒãããã«ãªãããã®åŸãŸããªãã圌女ã¯ããªãã㣠ããªã¿ãªãŒã«åºããããŸãããããªãã㣠ããªã¿ãªãŒã¯ããããã®å€ãé屿¿ããªã¯ã¿ãŽã³ã®å€ãæ©èœã倱ã£ãæœèšã«ç¿»èš³ãæ±ããŠæã£ãŠããŸããã圌女ã¯ããã®ãªã¯ã¿ãŽã³ãã©ãã«ããã®ãã¯èšããŸããã§ãããéå»ã«èšåããããªã¯ã¿ãŽã³ ã°ã«ãŒããšåããã©ããã¯ããããŸããããããæããã«ã圌ãã®äžå±€éšã®èª°ãããå®å®ã®ãã¹ãŠã®ç§å¯ãšå°ççåœã®å
šèšç»ããã®æœèšã«ãããšåœŒãã«è©±ããŸããã
ãã®èšç»ã誰ããããããããã®ãã誰ãç¥ã£ãŠããŸãã ?ãã©ã³/ãã«ãã¥ã¯ ? ããã誰ã§ããã圌ãã¯ãããä¿¡ããŠããã®ã§ããã¡ããè±èªã§ã¯ãªãã£ãã®ã§ã翻蚳ãå©ããããã«æããã«ãããã®ã·ãŒããå¿
èŠã§ããã
ã«ã·ãã¡ãŒéåã¹ãŒããŒã³ã³ãã¥ãŒã¿ãŒ
圌ãã¯ããšãŒãã« ãã©ãºãã䜿çšããŠã«ã·ãã¡ãŒéåã¹ãŒã㌠ã³ã³ãã¥ãŒã¿ãŒãèµ·åãŸãã¯æ¥ç¶ããããšããŠããããããç§ãã¡ã®ãã©ãºã ãã£ãŒã«ãã«åœ±é¿ãäžããŸãããããã¯ç§ã«ãšã£ãŠæ°ãããã®ã§ããç§ã¯ãããããäœãè¯ããã®ãåºãŠããã¯ãããªãã£ããšæããŸãã圌ãã¯ã¯ãšãŒãµãŒãæ¥ç¶ããããšããŠããŸããã ? ç§ãæ£ããã¹ãã«ãæã£ãŠãããã©ããããããŸããããããã圌ãã¯ã䜿çšã§ãã ARCHONS ãå«ãŸããŠããå¯èœæ§ããããšèããŠããŸããã圌ããã¬ã³ãç·ãéä¿¡ããããã«äœ¿çšããŠããã³ã³ãã¥ãŒã¿ãŒã¯ãè»ããããã®æœèšã®ããã€ããååšããããšããç¥ããªããããæ£èŠè»ãç¥ãããå Žåã«åããŠã«ã¶ãã¹ã¿ã³ã«ãããŸããã
ãã ã¯ã圌女ãšåœŒå¥³ã®ããŒã ãé€ããŠã誰ããã®æ
å ±ãæã£ãŠããªããšèšããŸããã
ã¢ãŒããã¹ã
ãšããã§ãã¢ãŒããã¹ãã¯äžçäžã®æ¿åºãè»éãè°äŒããããŠå°çãéããããšãããªãã·ã¥ãŒããŒã®ãããªäººã ã«æ å ±ãæäŸããããšæžåœã«åããŠããŸãããã ã¯åœŒãã«ãèªåã®åœã®äººã ã«æ³šæãæãå§ãããããããªããã°åœŒãã¯å¿ èŠãšãããªãã ãããšèŠåããã圌ãã責任è ã ãšæãç¶ãããã®ãªãã圌ãã¯ããããçµæ«ã奜ãã§ã¯ãªãã§ãããã圌女ã¯ãŸããæå³çã«ã«ããã(人å)ãã¶ãäžããäºæž¬ããããã«ãããã¡ãããã¹ãŠåŒãåºãããšäŒããŸããã圌女ã¯ãããã®ããã¡ãã®äŸãæããŸããã§ããããé€(ãã)ãäœã§ããã圌女ã¯å¿ èŠãªãã®ãæã«å ¥ããŸããã
æ°ãããŠã€ã«ã¹ | ã¯ãªããã³ãã«ã¹ç
圌ãã¯ãåã¢ããªã«ãšã¢ã¶ã³ããŒã¯ã®äžã«ããæ°ãããŠã€ã«ã¹ããªãªãŒã¹ããããšããŸãããããã¯å®éã«ã¯ãã¯ãªããã³ãã¯ã¹çãŠã€ã«ã¹ãšåŒã°ããçèã§ããã圌ãã¯ããã猶ã«è©°ããŠäžçäžã«åºè·ããããšããŠããŸãããåœåå®å šä¿éçã¯ãã«ããããã«ããåœå¢ãè¶ããŠãã£ãŠãããã£ãã¹ã¿ãŒã®ããã€ããå®éã«ååããŸããããã ãèšåããŠããããã«ãåãžã®å°ããªäžåœã§ãã
åœä»€ã¯ãé»ã倪éœã®éšå£«å£ã®ã¡ã³ããŒã§ããäžåœã®å°è»ããæ¥ãŸããããã®å°è»ããããã©ã®ããã«æ¯æãã€ããã§ããããé€ããŠïŒãã ã¯ããããããããã«åœŒã«èšã£ã人ã ã¯ããããã圌ã«å¥çŽãäžãã人ã ãšåãã§ã¯ãªãããšã圌ã«ç¥ãããããšããŸããã

ã¯ãªããã³ãã«ã¹çïŒ çç¶ãæ²»çã蚺æã... äž»ãªçç¶ãšããŠã以äžã®ãããªãã®ãæããããŸãïŒ çºç± åŠæ æ èžéšäº¢é²ç çã¿ïŒççãèµ·ããŠããéšåã«èµ·ããéãçã¿ã§ã次第ã«åŒ·ããªã ããããããïŒ å³åœãéåžžéçç£ç åè¡ (è¡ã®æ··ãã£ãç°ãåºãïŒ é ç èŠåã®å€åïŒãŒããããäºéã«ãªã ããžã§ã³ã ... https://www.emedicinehealth.com/cryptococcosis/article_em.htm
ã«ã³ãžããšãŠã«ã«ããªãŒã¹ãã©ãªã¢
çæã®ç
æ°ã«é¢ãããããªã調æ»çµæãåºãŠããŸããããã ã¯ãã«ã³ãžãã¯äººéã«èªç¶ã«ååšããã®ã§ã¯ãªãããã©ã³ããåŸããã®ã§ããããšãçºèŠãããã·ã§ãã¯ãåããŠãã人ã¯ããªããšæããŸããäžçã®å€ãäžæå²©ã® 1 ã€ã§ãããŠã«ã«ã®äžã«ã¯ãããã 13 ã®è»äºã°ã«ãŒãããæ¥è§Šãåããé人éã®åºå°ããããŸããã圌ãã¯ãå€ãã®åé¡ãåŒãèµ·ããå¯èœæ§ã®ããããããå Žæã§ã«ã³ãžãã®çºçãåŒãèµ·ããããšããŸããã
幞ããªããšã«ããã®åé¡ã解決ãããŸãããããã¯äžæããããšã³ãã©ãŒãµãŒãæ®ããåŠçããŸãããããããå€ãã®éåšæ³¢æ°ãéä¿¡ããªããã°ãªããªããããå€ãã®é害ãçºçããŸããã

ããRNAã¯GNAã§ãã
ç§ãã¡äººéã® RNA ã¯ãããšããš GNA (Glycolic Nucleic Acid) ã ãã§ããããããã¯ãç§ãã¡ã®æè²äœãäºãã«è©±ãããšãå¯èœã«ããå容äœã§ãã
圌ãã¯ç§ãã¡ã®å
ã® DNA ãç Žå£ããŸãããç§ãã¡ã¯ 36 æ¬ã®éãæã£ãŠããŸããããä»ã§ã¯æåã¯ãžã£ã³ã¯ã§ã¯ãªãã£ããžã£ã³ã¯ DNA ãæã£ãŠããŸãã圌ãã¯å容äœãRNAã«çœ®ãæããŠãã³ãã¥ãã±ãŒã·ã§ã³ã«åé¡ãåŒãèµ·ãããã€ã³ã¿ãŒã»ãã¿ãŒãšããŠæ©èœãããŸãããå
ã®å容äœã¯ãRNA ã«çœ®ãæãããŸã§ãç§ãã¡ã®äœãéãã¹ããªãã¥ã¢ã«ãªåŽé¢ã®ãšãŒãã« ã¬ãã«ãšã®æ¥ç¶ãå©ããŠãããã®ã§ãããã®ããããžã£ããæçšãã人ã®äžã«ã¯ãå®éã«ç¥ããåãé¢ãããŠãããšæãããšèšã£ãŠãã人ãããŸããããŸãã«ãããç®æšã§ããã
ã©ã€ã ãã¿ãŒãœã³ç©ºè»åºå°ãšãã£ã³ã ãã³ãã«ãã³
äžçã®éèã·ã¹ãã ã«æ¥ç¶ãã詊ã¿ã¯ãã³ã³ãã¥ãŒã¿ãŒçšèªã§éåžžã«å€ã Prometheus ã·ã¹ãã ã䜿çšããããšãããšãã« Kim ã«ãã£ãŠçºèŠãããŸããã圌ãã¯ãã€ã¯ã python GLU èšèª (ãªãŒãã³ ãœãŒã¹èšèª) ã䜿çšããŠæ¥ç¶ããããšããŸãããããã¯ãã©ã€ã ãã¿ãŒãœã³ç©ºè»åºå°ã«ããã®ãŒããŸããããããæ¥ç¶ã詊ã¿ãã®ã¯åœŒãã ãã§ã¯ãããŸããã§ããã圌女ã¯ãŸããããããã£ã³ãã»ãã³ãã«ãã³ãŸã§ããã®ãŒããŸããããã§ããã¯çµãããKim ã¯èªåã® GLU èšèªãã€ã³ã¹ããŒã«ãããšèšã£ãã
åé¿é³ ãã©ã€ã¢ã³ã°ã« è¶ é«åšæ³¢éä¿¡
æã«è·³ãè¿ããå°çå
šäœã«åé¿ãåŒãèµ·ããããã«ãããã€ãã®è¡æãšååããŠåé¿é³ã®äžè§åœ¢ããããŸãããããã¯ã¢ã³ãã§ããã圌ãã¯ãããäœåºŠã䜿çšããããšããŠããŸãããæºåž¯é»è©±ããã¬ããäžéšã®å·èµåº«ãä¹Ÿç¥æ©ã«æèŒãããŠããããããä»ããŠçºä¿¡ã§ããåšæ³¢æ°ãéä¿¡ããããšããŠããŸããã圌ãã¯ã©ãã«ã§ãããŸãããããã¯ãããžãã£ããŸãã¯ãã¬ãã£ããªæ¹æ³ã§äœ¿çšã§ãã倩ç¶ã®ãšãã»ã³ã¹ãã«ããŒã§ããã¯ãªã¹ã¿ã«ã§ãã£ã±ãã§ãããããã®äžã®é(ãããGOLD)ã¯åœŒãã«ãã£ãŠäœ¿çšãããŠããŠãåºæ¬çã«ç§ãã¡å
šå¡ã殺ãããã«éæ¹ããªãé«ãåšæ³¢æ°ãéä¿¡ããŠããŸããã
ãã ã¯ãããã 13 è»ã® 1 ã€ã䜿çšããŠããæåŸã®åé¿é³ã®äžè§åœ¢ã§ãããšèšããŸããã圌女ã¯ãŸããDARPA ã®åç·ã§ãã NASA ã®ããã§ã¯ãªãã£ããšãè¿°ã¹ãŸããã圌女ã¯ãæ¥ç¶ã倱ãããããšã«ã€ã㊠NASA ã«èª¬æããŠããããã«èãããŸããã
ãã©ã³ãšã®å¥çŽã¯2022å¹Žã«æéåã
ãã©ã³ãæåŸã«æ¥ããšãã圌ãã¯ãã¥ãŒãžãŒã©ã³ãã«å°çããŸããããã¹ããã€ã€ãŒã«è² ããã®ã§ã圌ããæ»ã£ãŠãããšããåæããããŸããããã®å¥çŽã¯ä»å¹Žå€±å¹ãããã¯ããä¿è·è
ãã¯å¿
èŠãããŸããã
ãšã³ãã©ãŒãµãŒã¯çŽ300äžå¹Žããã®é»éè¡åž«ã远ã£ãŠããã圌ã¯å¿
èŠãªéãããã«æ»åšããŸããããã®æ··ä¹±ãæçµçã«çä»ãããããããããã圌ã¯åŒéããã§ãããã
ãã ã圌女ã®ãªã¢ã«ãã¹ããªãŒã·ãªãŒãºã§ãšã³ãã©ãŒãµãŒã«ã€ããŠãã£ãšè©±ããŠãããããšãé¡ã£ãŠããŸãã圌ã¯ç¢ºãã«ç§ã®å¥œå¥å¿ãæã£ãŠããŸãã圌ã人éãªã®ãå¥ã®çš®æãªã®ãããã¹ããã€ã€ãŒãšã®å€§ããªæŠããã©ãããå§ãŸã£ãã®ãã圌女ãèšåããã®ãèããããšããããŸããã
ãšã«ãããåœŒå¥³ã¯æ¬¡ã®æŽå²ã®ãšããœãŒãã§ãã©ã³ãšã®ãã®åæã«ã€ããŠãã£ãšã«ããŒãããšèšããŸããã
ãã¢ã³ã»ãªãµãã³ã æ¿æ²»ãã£ã¯ãµãŒ
ãã ã Juan O'Savin(ãã¢ã³ã»ãªãµãã³) ã«ãããšã圌㯠Q ã ãšäž»åŒµããããšããŠããŸãããããã§ã¯ãªããJFK ãžã¥ãã¢ã§ããããŸããããããããã£ã¯ãµãŒã§ããã¹ãã£ã³ãã«ãšåŒã°ããã·ãªãŒãºã®ãªãªãã¢ã»ããŒãã®ããã ãšæããŸãããšã«ããããã£ã¯ãµãŒãšããªãŒã©ã³ãµãŒãäžç·ã«ãªã£ãŠäœæŠãç«ãŠãŸãããã£ã¯ãµãŒã¯æ¿æ²»çãã£ã¯ãµãŒã§ããããããã¢ã³(Juan O'Savinãã¢ã³ã»ãªãµãã³)ãããŠããããšã§ãã圌ã¯ãã©ã³ããããç¥ã£ãŠããŸãããå®éã«ã¯åœŒã¯ãªã¹ãã® 107 çªç®ã® DARPA ã®å°éå®¶ã§ãã
ãã ã¯ãå
¬è¡šãããããŒãžã§ã³ã«ã¯æ³šæãæããªãããã«èšã£ãã圌ã¯ãéžæãæäœããããšæžåœã«åªåããŠããæ¿æ²»çãã£ã¯ãµãŒã§ãããçŸåšã¯ãžã§ãŒãžã»ãœãã¹ãšæŠã£ãŠããè人ã§ãã
ãã ãåœŒã«æããããšããŠããããšã¯ã圌ãå
šå¡ãåã人ã«å ±åããããšã ãšæããŸãã圌ãã¯åã人ããä»äºã奪ã£ãã圌ãã¯åœŒããæã£ãŠãããããªäžåœäººã§ã¯ãªãã圌ã«ãéãæãã€ããã¯ãããŸããããããã°ã©ã ãã¯ãããŸããã圌ãæåã«æ³šæãåãããšããããã¯åœŒå¥³ã§ãããç§ã¯åœŒã圌女ãä¿¡ãããšã¯æããªãã
ãã©ã³ãã®ããš
ãã©ã³ããæŒããŠããã®ã¯CIAã®ç·ã§ãã
ãã ã¯ã圌ããåã³Qã®ç©èªã宣äŒãå§ãã2024幎ã«åºéЬããã ãããšäºæž¬ããŠããŸããããã©ã³ãã®åäŸãã¡ã圌ãã®CIAãã³ãã©ãŒããããŠåœŒãã®ãã£ã³ãã«ãããã¹ãŠã®äººã
ã¯ãç©èªãæ°žç¶ãããããšãéžã³ãŸããã
圌ã(ãã©ã³ãå¢)ãåã³covidããªã¢ã³ãã®ç©èªãæ°žç¶ãããããšã«ããããã«ããããã®äººã ã¯äœããã¹ããããããããããã®å°è»ã¯æ°ããåœä»€ãåããŠããªããããäŸç¶ãšããŠå€ãåœä»€ã«åŸãããšããŠããŸããæéãçµãŠã°ã圌ããã©ãã ãæ··ä¹±ããããããããšæããŸãã
ããã€ãã®ä»ã®ãã®
圌ããåãã€ãããšã¯ä¿¡ããããªãã®ã§ãäœäººãã®å°è»ãšã€ãšãºã¹äŒå£«ãçã£ãŠããŸãã
ãã ã¯ããã«ãã¥ã¯ãéè¡ã·ã¹ãã ã«ã€ã³ã¹ããŒã«ããããã€ãã®ã³ã³ãã¥ãŒã¿ãŒã«æ®ã£ãŠããæãæ¬è³ªãçºèŠããŸããã圌ããéãåŒãåºãããã«äºæ¬¡æ¿èªãäžããªããã°ãªããªãã£ããããã®ã³ã³ãã¥ãŒã¿ãŒã圌女ã¯ãããäžæããŸããã
è±åœã®äžéšã®é åºè ã¯ãã·ã¹ãã ã«æ»ãããšããŠãPromis ãš Echelon ãåã³å§åãããããšããŸããããããã圌ãã¯ãã¹ãŠã倱ããŸããããããã¯ä»ã§ã¯å°ããªããšã§ããããã ã«ããã°æåŸ ãããŠããŸãã
ãã ãšãšã³ãã©ãŒãµãŒã¯ããã«å€ãã®æœèšãç Žå£ããŸããããŸã åãæ®ãããŠãããã®ããããŸãããæè¡çã«ã¯ã»ãšãã©æ®ã£ãŠããŸããã
æåæ§ãšãã«ã®ãŒå µåšããžã§ãŒãžã¢ ã¬ã€ã ã¹ããŒã³ãåãåºããŸãããæå³ã¯æ¬è³ªçã«ãããå€ãã®ãããã¬ã³ãã宣äŒããããŒããŒãšãã®ãŒãã³ãæ¯æããããšã«ãã£ãŠç©èªãéå§ããããšã§ãã.
æ®ãã®ä¿®åŸ©äžå¯èœãªäººéãä»å©ããŠããã®ã¯èª°ã§ãã?
ã©ããã誰ãããªããå®éããã ã«ããã°ããããã®ååšãæœèšã®æ€å»ãæãŸãªã人ã¯ã©ãã«ãããŸãããããã«ã¯ã5 ã®è©è°äŒã9 ã®è©è°äŒããŠãããŒãµã«è©è°äŒããšã³ãã©ãŒãµãŒãããã³ãã¥ãŒã¢ãŒã¹è©è°äŒãå«ãŸããŸãã圌ãã¯çã圌ãã«ããããããŠããããããŠããŠã圌ããæãã§ããŸãã
ç§ãã¡æ®éã®äººéãããã§ããç§ãã¡ã¯ãã®åè»äºæ ãèŠãã®ã«ããªãããããããŠããŸã!

ã¯ãªã¹ãã¹ ã¹ãã€ã·ã¹ã®ååš
ã¢ã«ããªã³ã® 12 ã®ã©ã€ãããã£çäœã®ãããããéããŠã ãã®ç¹å®ã®æ¬¡å
çäœã®æé«äœã®ååšãŸã㯠ã¯ãªã¹ãã¹ ããž ã°ã¬ã€ã« ãã³ã°ãååšããŸããããã¯ã 12ã®éšæ ã®ããããã«ããã ã¯ãªã¹ãã¹ãšãœãã£ã¢ã® çµ±äžããã ããããšã¹ã¿ããã®å
·çŸåã®äººé¡ã®æé«ã®æå°±ã®ããã®ç¥èãªç®çãä¿æããå€§èŠæš¡ãªåæ»ã®ååšã§ãããããã¯ãã¹ãŠã®å人ã®äžã«ååšããå
ãªãããªã¹ãã«ãã£ãŠéæããããšãã§ããŸããã¢ã«ããªã³ ã©ã€ããã㣠å
ã ãã§ãªããå°äžã«çãŸãããæ·±ãæŽçªã溶岩æŽã«é ãããŸãŸã§ãã¹ã¿ã·ã¹ ã¹ãªãŒãç¶æ
ã«çãŸã ã¯ãªã¹ãã¹ã¬ãŒãã£ã¢ã³ã®ååšããµããŒãããŠããŸããÂ
å°çã®å°æ®»ã«å
ãŸãã13 ã®ãã©ãŽã³ã®ååšã¯ãã¬ã€ ã©ã€ã³ ã®å®è·è
ãšããŠé·ãéããã«ååšãã ãŽãŒã«ãã³ ãã©ãŽã³ã®åµ ãå²ã ãã ãããªã¹ãã®åãç®èŠããããŠä¿è·ããæºåãã§ããŠããŸã ã圌ãã¯ãææã®éåæèã髿¬¡å
ã®æèãšèªå·±èªèã®ã¬ãã«ã«éããå°çèŠæš¡ã®ç®èŠãã®è»¢æç¹ãçºçãããŸã§ãå°çã§ç ã£ããŸãŸã§ããŸããã¢ãŒãµãŒã®å°é ã«ãããã¢ã«ããªã³ã§ã®åœŒã®ç®èŠãã¯ã ãããã®åæ»ããååšã®äžã§ãããªãã°ããŒãã«ãªç®èŠããéå§ããããã§ããããã¯ãé²åãã ã¯ãªã¹ãã¹ã® ååšãã2000 幎以æ¥ã¹ã¿ã·ã¹ ã¹ãªãŒãç¶æ
ã«ãªã£ãŠããããš ãçè§£ããããã®ãã®ã§ãã
ã«ã·ãã¡ãŒã®åä¹± ãšæé»æä»£ãéããŠã圌ãã®ã¯ãªã¹ãã¹æèäœãå©çšããŠã2012幎以éã®ã¿ã€ã ã©ã€ã³ã®ããŒã«ã·ããç Žå£ããå°çãæãããšãã§ããŸãããå®å®ã®ã¯ãªã¹ãã¹ã®ååšã¯åœŒãã®åµé ç©ã«å
·çŸåããã圌ãã®äœã¯åµé ç©ã§ããããããã£ãŠ ã¢ã«ããªã³ã¯ ãå€§èŠæš¡ãªå€æ¬¡å
ææç³»ãæ§æããè€éãªæ§é ã®å
šäœã§ãããçµåãããæèäœã®åæ ã§ãã12 ã® Maji Grail Kings ã¯ãçŸããçåœãNAA ã«ãã£ãŠåŸæããã䟵ç¥ããããšããææãé¢ããããšã¯ãããŸããã§ããã圌ãã®äººéã®éšæãšåžæ°ãèæ®ºãããŠãããšãã圌ãã¯ããã§åæ»ããŠããŸããã圌ãã¯ãåããªã¹ããšã®æãæãã¿ã€ã ã©ã€ã³æŠäºã®éãèŠçããé ãããç ã£ãŠããéãã£ãšç§ãã¡ãšäžç·ã«ããŸãããåæã«ã圌ãã¯ã NAA㮠䟵ç¥äžã«ææã®åšæ³¢æ°ãæ¥éã«äœäžããåºæ¬çãªåšæ³¢æ°ã圌ãã®éåžžã«é«ãæèã¬ãã«ãšå·šå€§ãªãµã€ãºã®ãªãŒã©ãã£ãŒã«ãããµããŒãããã®ã«ååãªã»ã©é«ããªãã£ããããææ©çãªKrysticã®ç®èŠããç¶æ
ã§ã¯ååšã§ããªãããšã«æ°ä»ããŸããã圌ããéžæããããã«ææã®ã©ã€ãããã£ã«æ¥ç¶ããããŸãŸã§ããå Žåããã®äœå¯åºŠã§ååšãç¶ããå¯äžã®æ¹æ³ã¯ã鿢ããŠç ãã«ã€ãããšãšããšã€ãªã¢ã³ãã·ããªãŒã§ã®äœ¿çšãæåŠããããšã§ãã. æèã¯ãã©ãããŸãã¯çãŸãå€ããã«ãªãµã€ã¯ã«ãããŸãããããè¡ãããã«ã圌ãã¯ç§ãã¡ã ã¬ãŒãã£ã¢ã³ ãã¹ã㮠代衚è
ãã¯ãªã¹ãã¹ ã¹ã¿ãŒã·ãŒã ã圌ãã®ããšãå¿ããªãããã«é Œããã¢ã«ããªã³ã§åœŒããç®èŠããããã®ãå©ããé©åãªæãæ¥ãã ãååããŠç§ãã¡ã®ææãããšã€ãªã¢ã³ã®è
åšãæã¡è² ããããšãé Œãã«ããŸããã ææãå æè¡ã®æä»£ãšãã®åŸã®ã¿ã€ã ãµã€ã¯ã«ãéããŠæéããããŠé²åããåºæ¬çãªææåšæ³¢æ°ãäžæããããã€ã¢ã¢ã³ããµã³DNAãçµã¿ç«ãŠããšãå°çã®ãã®æ¬¡å
çå
ã«åæ»ããŠååšããã
æé«ã®è³é«ã®ååšãŸãã¯ã¯ãªã¹ãã¹ããžã°ã¬ã€ã«ãã³ã°ã掻æ§åãããŸã ããããã®æè屿§ãäœçŸããããããäŒéããããã«ç©è³ªã®é¡çŸã«ãç§ãã¡ã®ããšã¯ ãããã®ç³»çµ±ã§ããã«éãããã¹ã¿ãŒã·ãŒãã¯ãç§ãã¡ã®ã¹ããªãã¥ã¢ã«ãªã€ãã·ãšãŒã·ã§ã³ ã¬ãã«ã«å¿ããŠããããã®ã¯ãªã¹ãã¹æè ã®å±æ§ãåãåãããšã«ãªããŸã ã
ãããã éåšæä»£ã®ã€ãšã·ã¥ã¢ãšããªã¢ã®ãœãŒã©ãŒ ããŽã¹ ã®é¡çŸã§ãã ãå
·çŸåããã 8 次å
ã®è±¡åœ¢æåã®æ£ãšæã®ä¿æè
ãšããŠã圌ãã¯æ¬¡ã®ã¯ãªã¹ãã¹ ã¬ãŒãã£ã¢ã³ãã¢ã»ã³ã·ã§ã³ ãµã€ã¯ã«ã®æçµæ®µéã§ç®èŠããããã®ã©ã€ããã㣠ã¢ãŒããã¯ãã£ãç¯ããŸãã ãä»èããããšã¡ã©ã«ã ãªãŒããŒã®ã¢ã«ããªã³ã® åã ãéã㊠æç ã®ã¯ãªã¹ã¿ã« ããŒãã®æŽ»æ§å ã¢ãŒãµãŒçã¯ãªã¹ãã¹æè ãžãšäžæã ãææå°çã® 11 次å
ã®æ£ãšæã®ä¿æè
ãç®èŠããè¡åãèµ·ããæã§ãã 倱ããã ç¥ ãš ã¯ãªã¹ãã¹ã®çåœãåãæ»ããããç®èŠããã¢ã«ããªã³ ã®äžããã¢ã«ããªã³ã®å€ªéœ ç«ç ãš ããžã»ã°ã¬ã€ã«ãã³ã°ãã¯ãªã¹ãã¹çã®çãšããŠç«ã¡äžããã圌 [ã¢ãŒãµãŒ] ã¯çŸåšã è±åœã§ç®èŠãããã³ã°ã·ãã ã¢ãŒã¯ ãéã㊠ã¯ãªã¹ãã¹ ã¹ãã€ã·ã¹ ããŒã€ã³ã° ã®äžççãªç®èŠããéå§ããŠããŸããããã«ãã£ãŠãå°çã«å®å®ã®æ£çŸ©ãããããããã«ãæ
æ²æ·±ãç¥ã®ç·æ§çãªã¯ãªã¹ãã¹ã®æŠå£«ãè¿ããŸããåœŒãææäœã§ç®èŠãããšãåœŒã¯æŽå²ãåºæ¥äºãã¿ã€ã ã©ã€ã³ã®å
šäœãæãåºãã倩䜿ã®ãããªäººéã®DNAã«èšé²ãããŠããæ£ç¢ºãªçްèèšæ¶ãäœçŸããä¿åããçåœãšèªç¶ã®ãããã詳现ãèŠããŠããŸããæçãç®èŠãã圌ã®åµé ç©ãå
·çŸåããããã«æ»ã£ãŠãããšã ãäœã倱ããããå¿ãããããããããšã¯ãããŸããã ããã¯ãå
šäººé¡ã ã¢ã«ããªã³ ã©ã€ãããã£å
ã®å€ªéœã®ããŽ ãšæã®ã·ã¹ãã ã«æ¥ç¶ãããŠããå®å®ã®ã¯ãªã¹ãã¹æè ã®æ°žé ã®å
ã®äžã§ãã©ã³ã¹ãšçµ±äžãå埩ããããã®ãæãããã®ããè¡åã«ããã æçã®ç¥èãªèšç»ã§ããç§ãã¡ã¯æããæ¥ãŸããããªããªãç§ãã¡ã¯æã ããã§ããããã¯ãæ
æ²æ·±ãæ£åœãªã¯ãªã¹ãã¹å€ªéœçã®ææå°çãžã®åž°éãææã® ããžèæ¯çã¢ãŒãµãŒã®åŸ©æŽ»ã埩掻ãã 倪éœèãã«ãšã«ã®æ²¹ãããããããªã¹ããèæ¯ ãš ãœãã£ã¢ã®èæ¯ ã®ä¿è·è
ãšããŠç«ã¡äžããããš ã®æ·±ãæå³ãä¿æããŠããŸããããã¯ãå°çã®ã³ãºãã㯠ããŒãã®åçã§ãã [1]
12 ã®ããž ã°ã¬ã€ã« ãã³ã° ããŒã¯ ã€ãŒãªã³ ã®é ã ãã®ããã°ã©ãã£ã㯠ã¢ãŒããã¯ãã£ã®ã¢ã«ããªã³ ã©ã€ããã㣠㚠ã³ãºãã㯠ã¯ãªã¹ãã¹æèã® ä¿æè
ã¯ãå°çå¯åºŠã®æãäœãæ¯åã«çœ®ãããããã§ç ãç¶ããŸããã ã¯ãªã¹ã¿ã« ã¹ã¿ãŒãã¡ããªãŒã¯ãã¢ã»ã³ã·ã§ã³ ãµã€ã¯ã« äžã«èŠéããããã«æ»ã£ãŠããŸãã ãã¬ãŒãã£ã¢ã³ãšããŠããããã¯å
ã® 12 人ã®ããž ã°ã¬ã€ã« ãã³ã°ãšãå°çã ã¿ã© ã ã¬ã€ã¢ ã® ã¢ã«ããªã³ãç®èŠããããããšã«ãã£ãŠ ç§ãã¡ãæ»ã£ãŠããã¯ãªã¹ãã¹ã®å®¶æã®ã¡ã³ããŒã§ãã ç¥ã®äžçã®ç²Ÿç¥çãªå®¶ã«æ»ããŸãã[2]åºå
ž: Christos Stasis Beings â Ascension Glossary
PJZ
ãã ã®UNNç¶æ³å ±åã«åºã¥ãé¢é£èšäº
ãã³ããªãŒã»ã¢ã³ã»ãŽãŒã²ã³ãå¥åããã ã»ããã·ãã«ããšã¯èª°ã§ãã ?
ãžã£ã¹ãã»ãšã³ãã¯ãŒã»ããŒ
ã
ãã ãã㯠ãã³ããªãŒã»ãŽãŒã°ã§ã³ãKimberly Goguenã§ãæç§°ã ãã ã»ãŽãŒã°ã§ã³ãKim Goguenã§ããã人é¡ã®ç¶çãã¯ã¢ãã³ããã§ããããæ¯åïŒãšã³ãªã« ãã¡ïŒã«å°çã®æ¯é
æš©ãæž¡ããå°çãå»ã£ãŠããŸããã
ãã³ããªãŒã¯ãšã³ãªã«ã®æªè¡ãç¥ããæãã®çšã¿ã€ãã§ãšã³ãªã«ã倱ç¥ãããå°çããéå»ããããããã¯2011幎ããåã§ããã以æ¥ããã³ããªãŒã¯ã人é¡ã®çãã®åº§ã«ã€ããŠããããéãå«ããå°çå
šäœã管çããŠããŸãã